Abstract
RHP is a recently described serum protein which inhibits a number of physiologic functions of Clq unbound to Clr2×Cls2. In this report we show that sera from patients with rheumatoid arthritis contained elevated levels of RHP and of unbound Clq. Sera from patients with systemic lupus erythematosus contained normal levels of RHP and were characterized by deficits of Clq required to form Cl from existing levels of Clr and Cls.
Similar content being viewed by others
References
Rosano, C. L., N. Parhami, andC. Hurwitz. 1984, Serum levels of Cl sub-units in rheumatoid arthritis.J. Lab. Clin. Med. 103:313–321.
Rosano, C. L., N. Parhami, andC. Hurwitz. 1985. Isolation and purification of a Clq-anti Clq precipitin ring enhancing protein from sera of patients with rheumatoid arthritis.Biochem. Biophys. Res. Commun. 128:1288–1294.
Hurwitz, C., C. L. Rosano, K. E. Hechemy, andP. S. Satoh. 1987. Biochemical and immunological properties of RHP, a serum protein associated with rheumatoid arthritis.Fed. Proc. 46:612.
Rosano, C. L., J. A.Fox, K. E.Hechemy, N.Parhami, P. S.Satoh, and C.Hurwitz. Chemical and immunochemical studies of RHP, a serum protein elevated in rheumatoid arthritis.J. Immunol. (submitted).
Rosano, C. L., N. Parhami, andC. Hurwitz. 1979. The clinical significance of protein-bound hydroxyproline fractions in sera of patients with adult rheumatoid arthritis.J. Rheum. 6:656–663.
Rosano, C. L., N. Parhami, andC. Hurwitz. 1979. Determination of Clq in human serum.J. Lab. Clin. Med. 94:593–599.
Ochi, T., K. Yonemasu, andK. Ono. 1980. Immunochemical quantification of complement components of Clq and C3 in sera and synovial fluids of patients with bone and joint diseases.Ann. Rheum. Dis. 39:235–240.
Ochi, T., K. Yonemasu, R. Iwase, T. Sasaki, I. Tsuyama, andK. Ono. 1984. Serum Clq levels as a prognostic guide to articular erosions in patients with rheumatoid arthritis.Arthritis Rheum. 27:883–887.
Rosano, C. L., C. B.Braun, K. E.Hechemy, N.Parhami, P. S.Satoh, and C.Hurwitz, 1987. Inhibition of Clq functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.Complement (in press).
Reid, K. B. M., D. M. Lowe, andR. R. Porter. 1972. Isolation and characterization of Clq, a subcomponent of the first component of complement, from human and rabbit sera.Biochem. J. 130:749–763.
Prockop, D. J., andS. Udenfriend. 1960. A specific method for the analysis of hydroxy-proline in tissues and urine.Anal. Biochem. 1:228–239.
Hoekzema, R., A. J. Hannema, T. J. G. Swaak, J. Paardekooper, andC. E. Hack. 1985. Low molecular weight Clq in systemic lupus erythematosus.J. Immunol. 135:265–271.
Ziccardi, R. J., andJ. Tschopp. 1982. The dissociation properties of native Cl.Biochem. Biophys. Res. Commun. 107:618–623.
Scheffe, H. 1959. The Analysis of Variance. New York, John Wiley & Sons.
Cochran, W.G. 1964. Approximate significance levels of the Behrens-Fisher test.Biometrics 20:191–195.
Bartlett, M. S. 1937. Properties of sufficiency and statistical tests.Proc. R. Soc. A 160:268–282.
Dickler, H. B., andH. G. Kunkel. 1972. Interaction of aggregated gamma-globulin with B lymphocytes.J. Exp. Med. 136:191–196.
Gabay, Y., H. Perlman, P. Perlman, andA. T. Sobel. 1979. A rosette assay for the determination of Clq receptor-bearing cells.Eur. J. Immunol. 9:797–801.
Tenner, A. J., andN. R. Cooper. 1980. Analysis of receptor mediated Clq binding to human peripheral blood mononuclear cells.J. Immunol. 125:1658–1664.
Tenner, A. J., andN. R. Cooper. 1981. Identification of types of cells in human peripheral blood that bind Clq.J. Immunol. 126:1174–1179.
Veerhuis, R., N. Klar-Mohamad, L.A. Van Es, andM. R. Daha. 1986. Enhanced binding and degradation of the Clq subcomponent of complement by thioglycollate-stimulated guinea pig peritoneal macrophages.Scand. J. Immunol. 23:581–587.
Bing, D. H., S. Almeda, H. Isliker, J. Lahav, andR. O. Hynes. 1982. Fibronectin binds to the Clq component of complement.Proc. Natl. Acad. Sci U.S.A. 79:4198–4201.
Pearlstein, E., J. Sorvillo, andI. Gigli. 1982. The interaction of human plasma fibronectin with a subunit of the first component of complement, Clq.J. Immunol. 128:2036–2039.
Tenner, A. J., andN. R. Cooper. 1982. Stimulation of a human polymorphonuclear leucocyte oxidative response by the Clq subunit of the first complement component.J. Immunol. 128:2547–2552.
Niven, I. P., andK. Whaley. 1986. Inhibition of Clq binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.Rheumatol. Int. 6:205–208.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosano, C.L., Parhami, N., Hechemy, K.E. et al. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 12, 351–360 (1988). https://doi.org/10.1007/BF00915770
Issue Date:
DOI: https://doi.org/10.1007/BF00915770